ArticleHaemophilia : the official journal of the World Federation of Hemophilia

Milds Matter-Feasibility of Emicizumab Prophylaxis in Mild Hemophilia.

Kyle Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.